Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127243731 | 12724373 | 1 | I | 20120110 | 0 | 20160906 | 20160906 | DIR | US-FDA-349814 | FDA-CTU | 69.59 | YR | M | N | 70.65000 | KG | 20160906 | N | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127243731 | 12724373 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | N | Y | 0 | 1 | DF | COATED TABLET | QD | |||||
| 127243731 | 12724373 | 2 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | N | Y | 0 | 1 | DF | COATED TABLET | QD | |||||
| 127243731 | 12724373 | 3 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 127243731 | 12724373 | 5 | C | MONTELKAST (SINGULAIR) | 2 | 0 | |||||||||||||
| 127243731 | 12724373 | 7 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 127243731 | 12724373 | 9 | C | XIFAXAN | RIFAXIMIN | 1 | 0 | ||||||||||||
| 127243731 | 12724373 | 11 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 127243731 | 12724373 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127243731 | 12724373 | 15 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 127243731 | 12724373 | 17 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127243731 | 12724373 | 19 | C | LACTULOSE. | LACTULOSE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127243731 | 12724373 | 1 | Transient ischaemic attack |
| 127243731 | 12724373 | 2 | Transient ischaemic attack |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127243731 | 12724373 | HO |
| 127243731 | 12724373 | DE |
| 127243731 | 12724373 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127243731 | 12724373 | Cerebral haemorrhage | |
| 127243731 | 12724373 | Contusion | |
| 127243731 | 12724373 | Epistaxis | |
| 127243731 | 12724373 | Gastrointestinal haemorrhage | |
| 127243731 | 12724373 | Mouth haemorrhage | |
| 127243731 | 12724373 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127243731 | 12724373 | 1 | 20120111 | 20120711 | 0 | |
| 127243731 | 12724373 | 2 | 20120712 | 20151013 | 0 |